Strs Ohio Ligand Pharmaceuticals Inc Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Strs Ohio holds 6,500 shares of LGND stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,500

Previous 7,400 12.16%

Holding current value

$1.31 Million

Previous $841,000 36.86%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$112.56 - $177.14 $101,304 - $159,426	-900 Reduced 12.16%	6,500 $1.15 Million
Q2 2025 Aug 04, 2025	SELL	$96.67 - $118.22 $9,667 - $11,822	-100 Reduced 1.33%	7,400 $841,000
Q1 2025 May 28, 2025	SELL	$105.14 - $122.23 $63,084 - $73,338	-600 Reduced 7.41%	7,500 $788,000
Q3 2024 Nov 01, 2024	SELL	$82.7 - $110.11 $57,890 - $77,077	-700 Reduced 7.95%	8,100 $811,000
Q2 2024 Aug 05, 2024	SELL	$68.53 - $87.91 $34,265 - $43,955	-500 Reduced 5.38%	8,800 $741,000

Q1 2024 May 13, 2024	SELL	$68.64 - $89.2 $116,688 - $151,640	-1,700 Reduced 15.45%	9,300 $679,000
Q4 2023 Jan 30, 2024	SELL	$49.57 - $72.63 $14,871 - $21,789	-300 Reduced 2.65%	11,000 $785,000
Q3 2023 Oct 26, 2023	BUY	$58.86 - $72.67 $88,290 - $109,005	1,500 Added 15.31%	11,300 $677,000
Q1 2023 Apr 27, 2023	SELL	$65.67 - $77.08 $78,804 - $92,496	-1,200 Reduced 10.91%	9,800 $720,000
Q4 2022 Jan 26, 2023	BUY	$61.72 - $96.74 $216,020 - $338,590	3,500 Added 46.67%	11,000 $734,000
Q2 2022 Jul 25, 2022	BUY	$74.52 - $117.06 $29,808 - $46,824	400 Added 5.63%	7,500 $669,000
Q3 2021 Oct 22, 2021	SELL	$102.33 - $144.73 $173,961 - $246,040	-1,700 Reduced 19.32%	7,100 $989,000
Q2 2021 Jul 26, 2021	BUY	$113.03 - $155.64 $655,574 - $902,711	5,800 Added 193.33%	8,800 $1.15 Million
Q1 2021 Apr 23, 2021	BUY	$99.52 - $215.83 $298,560 - $647,490	3,000 New	3,000 $457,000
Q3 2019 Oct 21, 2019	SELL	$86.25 - $120.16 $25,875 - $36,048	-300 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$107.38 - $129.34 $139,594 - $168,142	-1,300 Reduced 81.25%	300 $34,000
Q1 2019 Apr 19, 2019	SELL	$105.93 - $142.47 $5.16 Million - $6.94 Million	-48,700 Reduced 96.82%	1,600 $201,000
Q4 2018 Jan 23, 2019	BUY	$128.36 - $272.13 $6.03 Million - $12.8 Million	47,000 Added 1424.24%	50,300 $6.83 Million
Q3 2018 Oct 19, 2018	BUY	$211.18 - $274.49 $147,826 - $192,143	700 Added 26.92%	3,300 $905,000
Q2 2018 Aug 06, 2018	BUY	$150.77 - $207.98 $45,231 - $62,394	300 Added 13.04%	2,600 $538,000
Q1 2018 Apr 20, 2018	BUY	$138.63 - $182.62 $83,178 - $109,572	600 Added 35.29%	2,300 $379,000
Q4 2017 Jan 23, 2018	SELL	$128.36 - $147.04 $2.46 Million - $2.82 Million	-19,200 Reduced 91.87%	1,700 $232,000
Q3 2017 Oct 23, 2017	BUY	$120.91 - $137.94 $2.53 Million - $2.88 Million	20,900	20,900 $2.85 Million

Others Institutions Holding LGND

# of Institutions

342

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account